Moderna Non-GAAP EPS of $5.24 beats by $0.75, revenue of $4.75B beats by $800M
Moderna (NASDAQ:MRNA): Q2  Non-GAAP EPS of $5.24  beats by $0.75.
Revenue of $4.75B (+9.2% Y/Y)  beats by $800M.
Shares +3% PM.